In GBM, CCR2 knockout mouse models revealed an inverse correlation between macrophage-identified MDM and microglia-identified MDM, suggesting that the antitumor effects of CCR2 blockade may be more closely associated with modulating microglial responses than MDM inhibition. Here, CCR2 is linked to glioblastoma.